September 20, 2021
Laboratorio Varifarma SA, a company focused on complex therapies and orphan diseases, and devoted to increasing the life expectancy of the patient announce they have signed an exclusive distribution and licensing agreement for TEPADINA® in Argentina and Chile with ADIENNE Pharma&Biotech, an integrated biopharmaceutical group of companies based in Lugano (Switzerland) which aims to develop a range of product candidates for orphan diseases for which existing treatment options are limited.
July 13, 2020
Varifarma is proud to present the BINAP Bioequivalence Study (Ibrutinib), which confirms its interchangeability with Imbruvica.
May 11, 2020
During May and June, we donated protection supplies to over 90 hospitals in Argentina, Chile, Ecuador and Peru.
March 5, 2020
On March 3 and 4, the launch events for Kyprolis® were held in the cities of Quito and Guayaquil, Ecuador.
February 17, 2020
The Commercial department participated in the annual 3-day convention to be trained in different pathologies and therapies.
February 14, 2020
Pleased to announce the new agreement of Varifarma Peru with Myriad Genetics for the quantity of its products in the country.
December 10, 2019
Committed to the prevention, diagnosis and treatment of breast cancer, we attended San Antonio's Symposium.
December 5, 2019
We spent a weekend at the annual meeting organized by the ASH to find the latest in hematology and oncohematology.
December 1, 2019
Varifarma presents Prolaris, an innovative test for Prostate Cancer.
November 7, 2019
Excited to announce a new indication: Lenvatib, approved under the ANMAT Approval Deposition: 7839/2019.
November 6, 2019
Step by our booth Nº2 to find our latest news!
October 25, 2019
By sharing knowledge and raising awareness of MDS diseases, we can help reduce stigma and foster a more informed and inclusive society.
October 19, 2019
Varifarma and VSA joined the pink ribbon campaign to raise awareness about the importance of having routine breast checkups.
October 15, 2019
We attended FUCA's dinner for the benefit of their teaching and research programs.
October 2, 2019
We attended the 2019's Congress of Hematology in Argentina.
September 24, 2019
We participated in the annual dinner of GEDYT: Blue Night.
September 22, 2019
We encourage to do the annual health checkups, in order to detect any sign and symptoms and find the adequate treatment.
September 3, 2019
We attended for the first time ever, the Argentinian and International Congress of Mastology.
September 2, 2019
Distribution and license agreements signed for Pracinostat in South America.
August 10, 2019
IgSC as Gammanorm® allows patients to be independent from hospital treatment.
May 10, 2018
This year, for the 13 th time in a row, we will be participating in the ASCO Annual Meeting.
March 28, 2018
Targeted therapy for locally advanced or metastatic non-small-cell lung cancer
September 28, 2017
KYPROLIS ® Significantly improves overall survival in patients with relapsed multiple myeloma.
May 22, 2017
We are pleassed to inform you about the incorporation of Celixafor®, Plerixafor 20 mg/ml 1 ampoule, to our hematology Vademecum.
May 22, 2017
Between the 2 to 6 of June, we will be part again of the world's biggest oncology congress: ASCO.